Skip to main content
Caplight Logo









Neurogram

Neurogram

Private
Atlanta, GeorgiaHealthcare & Life Scienceshttps://neurogram.com/

Last Round

Seed

Jul 31, 2025

Total Funding Raised

$4.4M

Company Overview

Neurogram is a medtech company that provides a comprehensive electroencephalogram management platform designed to assist neurological diagnosis with advanced tools, enhancing the medical routine with agility and precision.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service

AI Layer

Application

Keywords

EEG analysisMedical AINeurology AIEEG platformDiagnostic AIMedtechVertical SaaSClinical workflow automationHealthcare analyticsSleep study analysisPolysomnography analysisReal-time neuro monitoringNeuro ICU

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neurogram Comparables

Compare Neurogram with similar companies based on industry and business-model similarity.

Neurogram comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Piramidal
81%
LVIS Corporation
79%
Persyst Development Corporation
77%

Neurogram Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 31, 2025
Pre SeedNov 23, 2023

Neurogram Investors

Notable investors and investment history

Neurogram investors
InvestorRounds
Starship VenturesSeed, Pre Seed
Google for Startups AcceleratorSeed
Dorm Room FundSeed, Pre Seed
HeadlineSeed
Fusen FundSeed, Pre Seed
Caffeinated CapitalSeed, Pre Seed
Hustle FundSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 23, 2025

    Grew 32% QoQ from 19 to 25 employees.

  • Nov 15, 2025

    Grew 21% QoQ from 19 to 23 employees.

Neurogram Filings

Explore SEC and related filing metadata, where available.

Neurogram filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Neurogram's valuation, stock price, and market status.

Is Neurogram a public or private company?

Neurogram is a private company.

What is the current stock price of Neurogram?

Neurogram is a private company with no public stock price. No recent secondary market data is available.

How much is Neurogram worth (valuation)?

Valuation information for Neurogram is not publicly available.

Can I buy Neurogram stock?

Neurogram shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Neurogram's last funding round?

Neurogram's most recent funding round was Seed on July 29, 2025.

Who are the main investors in Neurogram?

Key investors in Neurogram include Headline.

Will Neurogram IPO soon?

No public IPO plans have been announced for Neurogram.

How can I track Neurogram secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neurogram's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAtlanta, Georgia
Employee Range25
Year Founded2021
Last FundingJul 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?